CVS, Barclays
CVS Stock Rises on Upgrade. Why Barclays Sees a ‘Compelling’ Opportunity.
Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.
CVS Health upgraded at Barclays on Medicare prospects
CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare Advantage business. Read more here.
Positive Report for CVS Health (CVS) from Barclays
CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026, bolstered by Walgreens' store closures.
Barclays ups CVS Health to Buy on positive margin outlook; shares rise
Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares to $82 from $63.
CVS Health (CVS) Gets a Hold from Barclays
Barclays analyst Andrew Mok CFA maintained a Hold rating on CVS Health (CVS – Research Report) today and set a price target of $63.00.
Top Stock Movers Now: Pfizer, First Solar, CVS Health, and More
Key Takeaways A higher-than-anticipated report on consumer inflation sent U.S. equities lower at midday.Solar power company ...
Yahoo Finance1d
CVS Health Corporation (CVS)
CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close. Barclays upgraded CVS Health Inc (NYSE:CVS) on higher ...
CVS Health to lay off nearly 3,000 workers primarily in 'corporate' roles
CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...
Seeking Alpha10d
CVS Health strategic review brings segments into focus
CVS Health (CVS) has lost ~22% in value this year ... the move will likely be an overhang for the stock in the near term. Barclays analyst Stephanie Davis disagreed. “However, we believe the ...
Investing1d
CVS Health Corp (CVSH34)
(Reuters) - CVS Health Corp (NYSE:CVS) on Wednesday forecast its adjusted profit to be in the range of $8.70 to $8.90 per share in 2023. This is higher than the new ...
CNN4y
CVS Health Corporation
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services ...